BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1299 related articles for article (PubMed ID: 23676191)

  • 21. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
    Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
    J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion.
    Psacharopulo D; Ferrero E; Ferri M; Viazzo A; Singh Bahia S; Trucco A; Ricceri F; Nessi F
    J Vasc Surg; 2015 Nov; 62(5):1219-26. PubMed ID: 26391459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial.
    Saxon RR; Chervu A; Jones PA; Bajwa TK; Gable DR; Soukas PA; Begg RJ; Adams JG; Ansel GM; Schneider DB; Eichler CM; Rush MJ
    J Vasc Interv Radiol; 2013 Feb; 24(2):165-73; quiz 174. PubMed ID: 23369553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
    J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
    Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R
    J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
    Kedora J; Hohmann S; Garrett W; Munschaur C; Theune B; Gable D
    J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iliac Artery Stenting Combined with Ipsilateral Open Femoro-Popliteal Revascularization and Its Effect on Bypass Patency.
    Piazza M; Squizzato F; Lepidi S; Menegolo M; Grego F; Antonello M
    Ann Vasc Surg; 2017 Oct; 44():282-288. PubMed ID: 28479462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent.
    Lenti M; Cieri E; De Rango P; Pozzilli P; Coscarella C; Bertoglio C; Troiani R; Cao P
    J Vasc Surg; 2007 Jan; 45(1):32-9. PubMed ID: 17210380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
    Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
    Hayes DJ; Dougherty MJ; Calligaro KD
    Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Results of Endovascular Treatment of TASC C and D Aortoiliac Occlusive Disease with Expanded Polytetrafluoroethylene Stent Graft.
    Bracale UM; Giribono AM; Spinelli D; Del Guercio L; Pipitò N; Ferrara D; Barillà D; Barbarisi D; Derone G; Benedetto F
    Ann Vasc Surg; 2019 Apr; 56():254-260. PubMed ID: 30339903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study.
    Guo X; Xue G; Huang X; Xie H; Liang W; Zhang J; Lin F; Yao T
    BMC Cardiovasc Disord; 2015 May; 15():44. PubMed ID: 26022244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience.
    Fischer M; Schwabe C; Schulte KL
    J Endovasc Ther; 2006 Jun; 13(3):281-90. PubMed ID: 16784314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral stent patency in fenestrated stent grafting for abdominal aortic aneurysm repair.
    Grimme FA; Zeebregts CJ; Verhoeven EL; Bekkema F; Reijnen MM; Tielliu IF
    J Vasc Surg; 2014 Feb; 59(2):298-306. PubMed ID: 24080136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
    Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
    J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid Revascularization Combining Iliofemoral Endarterectomy and Iliac Stent Grafting for TransAtlantic Inter-Society Consensus C and D Aortoiliac Occlusive Disease.
    Ray JJ; Eidelson SA; Karcutskie CA; Meizoso JP; DeAmorim H; Goldstein LJ; Karwowski J; Bornak A
    Ann Vasc Surg; 2018 Jul; 50():73-79. PubMed ID: 29481930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.